scorecardresearchDr Reddy's Labs Q3 net profit rises 77% to ₹1,247 crore

Dr Reddy's Labs Q3 net profit rises 77% to 1,247 crore

Updated: 25 Jan 2023, 05:17 PM IST
TL;DR.
  • Revenue from operations rose to 6,770 crore during the period under review as against 5,320 crore in the year-ago period, Dr Reddy's Laboratories said in a regulatory filing.
Revenue from operations rose to  <span class='webrupee'>₹</span>6,770 crore during the period under review.

Revenue from operations rose to 6,770 crore during the period under review.

(PTI) Dr Reddy's Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at 1,247 crore in the third quarter ended December 31, 2022.

The drug firm had reported a net profit of 706 crore in the October-December period of the previous fiscal.

Revenue from operations rose to 6,770 crore during the period under review as against 5,320 crore in the year-ago period, Dr Reddy's Laboratories said in a regulatory filing.

 

Article
What is EBITDA
First Published: 25 Jan 2023, 05:17 PM IST